PERSONIFICATION OF PHARMACOTHERAPY –STEP WITH TIME

Мавлянов, И, Мусаева, Д, Mavlyanov, I, Musayeva, D

Тиббиёт ва спорт · 2026-yil

Annotatsiya

The article reveals the main results of the study of genotyping ofpatients with acid-dependent diseases by the polymorphism C3435Tofthe MDR-1 gene and CYP2C19:681G>A*2, CYP2C19:636G>A*3 and CYP2C19:806C>T*l7 polymorphisms of the C YP2C19 gene, the frequency of their occurrence, combination, relationship and influence ofgenotypes of these genes of drug pharmacokinetics on the effectiveness of eradication therapy in patients with acid-dependent diseases in connection with the effect of genotypes on the metabolism ofproton pump inhibitors. The results of this study are of great importance in the selection of personal dosage regimens of drugs, pharmacotherapy of acid-dependent diseases, which are based on genotyping ofpatients by polymorphisms of the genes of drug pharmacokinetics - MDR-l and CYP2C19.

Maqola ma’lumotlari
MualliflarМавлянов, И, Мусаева, Д, Mavlyanov, I, Musayeva, D
JurnalТиббиёт ва спорт
Nashr sanasi2026-06-10
Son2
Betlar91-96
TilRus

Kalit so‘zlar

полиморфизм С3435Т гена MDR-1, ген MDR-1, полиморфизмы CYP2C19:681G>A*2, CYP2C19:636G>A*3 и CYP2C19:806C>T*17 гена СУР2С19, ген СУР2С19, кислотозависимые заболевания пищеварительной системы, эрадикационная терапия, polymorphism C3435T of the MDR-1 gene, MDR-1 gene, polymorphisms CYP2C19:681G>A*2, CYP2C19:636G>A*3 and CYP2C19:806C>T*17 of the CYP2C19 gene, CYP2C19 gene, acid-dependent diseases of the digestive system, eradication therapy, CYP2C19 genining MDR-1 geni C3435T polimorfizmi, MDR-1 geni, CYP2C19:681G>A*2, CYP2C19:636G>A*3 va CYP2C19:806C>T*17 polimorfizmlari, CYP2C19 geni, ovqat hazm qilish tizimining kislota bilan bog'liq kasalliklari, eradikatsiya terapiyasi

Ilmiy soha

Тиббиёт ва спорт jurnalidan boshqa maqolalar

Тиббиёт ва спорт — barcha maqolalar